News

Saffron may spice up the sex lives of those taking a selective serotonin reuptake inhibitor who experience libido issues.
SSRIs boosted the ability of T cells to kill cancer cells and suppressed tumor growth in both mouse and human tumor models.
A new drug for pulmonary fibrosis has reduced disease progression by more than 50% over a 52-week treatment in two clinical ...
Nerandomilast significantly slowed lung function decline and reduced mortality in patients with progressive pulmonary ...
A quick fix for ED has been on the wish list of millions of men for decades — maybe even centuries. If the internet is any ...
Q1 2025 net product revenue for ZORYVE® (roflumilast) was $63.8 million, a 196% increase compared to Q1 of 2024, and a 2% decrease compared to Q4 of 2024, due to typical first-quarter deductible reset ...
The research identified novel orally bioavailable p300-selective degraders that have therapeutic potential for difficult-to-treat prostate cancer and multiple cancers where the protein CBP is mutated ...
These can occur in many cancer types, and 40–70% of patients with these types of solid tumors either do not respond to immune checkpoint inhibitors or develop resistance during treatment.
New clinical data for zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor, demonstrates acceptable safety, tolerability, and encouraging initial antitumor activity in patients with KRAS ...
New York Post may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change. Let’s cut to the chase: erectile dysfunction ...